Difference between revisions of "Shultz LD, et al. Nat. Rev. Immunol. (2012) cited as Ref 650 in DOI: 10.1038/s41392-020-0110-5 (Q9913)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: First Author string (P149): Shultz LD, #quickstatements; #temporary_batch_1589996169159)
(‎Created claim: Fourth Author string (P152): Greiner DL, #quickstatements; #temporary_batch_1590155310798)
 
(9 intermediate revisions by the same user not shown)
Property / Second Author string
 +
Brehm MA
Property / Second Author string: Brehm MA / rank
 +
Normal rank
Property / Third Author string
 +
Garcia-Martinez JV
Property / Third Author string: Garcia-Martinez JV / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1038/nri3311 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 23059428 / rank
 +
Normal rank
Property / Publication Date
 +
2012
Timestamp+2012-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2012 / rank
 +
Normal rank
Property / Published In Name String
 +
Nat. Rev. Immunol.
Property / Published In Name String: Nat. Rev. Immunol. / rank
 +
Normal rank
Property / Volume
 +
12
Property / Volume: 12 / rank
 +
Normal rank
Property / title
 +
Humanized mice for immune system investigation: progress promise and challenges (English)
Property / title: Humanized mice for immune system investigation: progress promise and challenges (English) / rank
 +
Normal rank
Property / Page(s)
 +
786-798
Property / Page(s): 786-798 / rank
 +
Normal rank
Property / Fourth Author string
 +
Greiner DL
Property / Fourth Author string: Greiner DL / rank
 +
Normal rank

Latest revision as of 13:50, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Shultz LD, et al. Nat. Rev. Immunol. (2012) cited as Ref 650 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Shultz LD
    0 references
    Brehm MA
    0 references
    Garcia-Martinez JV
    0 references
    0 references
    2012
    0 references
    Nat. Rev. Immunol.
    0 references
    12
    0 references
    Humanized mice for immune system investigation: progress promise and challenges (English)
    0 references
    786-798
    0 references
    Greiner DL
    0 references